Corundum Systems Biology Welcomes New Chief Scientific Officer
Corundum Systems Biology, an investment firm dedicated to advancing systems biology solutions that improve human health and welfare, has appointed Jessica Schneider, PhD, MPH, as its new Chief Scientific Officer (CSO). This strategic move is intended to strengthen the company’s focus on innovative health solutions.
Dr. Schneider's Role and Responsibilities
In her new role, Dr. Schneider will be responsible for guiding the scientific strategy and execution across Corundum Systems Biology's varied portfolio of companies and development projects. Her work will encompass several key areas, such as artificial intelligence, microbiome research, and integrative-omics. Dr. Schneider will work closely with teams from the initial research phases to product development, offering vital scientific insight and strategic direction to help turn visionary concepts into practical health solutions.
CEO's Thoughts on the New Appointment
Hidehiko Otake, the CEO of Corundum Systems Biology, shared his excitement about Dr. Schneider joining the team. He remarked, "We are thrilled to welcome Jessica to Corundum Systems Biology. Her scientific knowledge and experience in developing cutting-edge solutions will be crucial as we continue to assist entrepreneurs and scientists in bringing their innovations to market." Dr. Schneider’s addition is expected to further the company’s mission of fostering innovation in healthcare.
Dr. Schneider’s Notable Background
Dr. Schneider comes with nearly 20 years of extensive experience in bacterial genetics and microbiome research. Before her role at Corundum Systems Biology, she was with Takeda Ventures, where she led investments in innovative therapeutic platforms. In her previous position as Director in Takeda Pharmaceuticals' Gastroenterology Drug Discovery Unit, she played a significant role in developing microbiome therapeutics, guiding projects from discovery through early clinical phases.
Prior to her time at Takeda, Dr. Schneider served as a Senior Scientist at Vedanta Biosciences, where she contributed significantly to the development of the company’s live biotherapeutics products platform. She has been instrumental in major advancements, such as the progress of VE303, which is currently in Phase 3 trials for recurrent Clostridium difficile infections. Dr. Schneider holds a PhD in Immunology and Microbial Pathogenesis from Cornell University and completed a postdoctoral fellowship at The Rockefeller University.
Jessica Schneider’s Vision for Innovation
Dr. Schneider shared her enthusiasm for the direction of Corundum Systems Biology, stating, "I'm passionate about the transformative potential of innovation leveraging a systems biology approach to human health. Corundum Systems Biology impressed me with their unique long-term, platform-based approach, supporting innovators from the earliest development stages to growth and impact."
She expressed her excitement about working alongside the company’s talented team, highlighting that Corundum Systems Biology not only provides funding but also fosters an environment that nurtures groundbreaking ideas.
About Corundum Systems Biology
Corundum Systems Biology is committed to enhancing human health and well-being by supporting pioneering companies in fields such as microbiome research and integrative-omics. The organization partners with early-stage ventures to convert innovative science into impactful health solutions. With a focus on the long-term success of its portfolio companies, Corundum Systems Biology combines extensive expertise with industry connections to provide access to exceptional health data.
This investment firm is part of Corundum Corp, an international innovation group that invests in transformative discoveries in neuroscience, systems biology, and artificial intelligence.
Company Contact Information
For more information about recent developments and activities, follow Corundum Systems Biology on LinkedIn or visit their official website.
Frequently Asked Questions
Who is Jessica Schneider?
Jessica Schneider is the newly appointed Chief Scientific Officer at Corundum Systems Biology, bringing extensive experience in microbiome research.
What are Dr. Schneider's responsibilities?
She will lead the scientific strategy across portfolio companies, focusing on innovative health solutions.
What is Corundum Systems Biology focused on?
Corundum Systems Biology is dedicated to advancing life-changing systems biology solutions for human health.
How does Corundum support entrepreneurs?
They offer funding, expertise, and industry connections to help innovators bring their ideas to fruition.
What is the long-term goal of Corundum Systems Biology?
The company aims to transform cutting-edge science into impactful health solutions for broader societal benefit.
